http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Intelligent LoRa-Based Positioning System
Jiann-Liang Chen,Hsin-Yun Chen,Yi-Wei Ma 한국인터넷정보학회 2022 KSII Transactions on Internet and Information Syst Vol.16 No.9
The Location-Based Service (LBS) is one of the most well-known services on the Internet. Positioning is the primary association with LBS services. This study proposes an intelligent LoRa-based positioning system, called AI@LBS, to provide accurate location data. The fingerprint mechanism with the clustering algorithm in unsupervised learning filters out signal noise and improves computing stability and accuracy. In this study, data noise is filtered using the DBSCAN (Density-Based Spatial Clustering of Applications with Noise) algorithm, increasing the positioning accuracy from 95.37% to 97.38%. The problem of data imbalance is addressed using the SMOTE (Synthetic Minority Over-sampling Technique) technique, increasing the positioning accuracy from 97.38% to 99.17%. A field test in the NTUST campus (www.ntust.edu.tw) revealed that AI@LBS system can reduce average distance error to 0.48m.
Jianne Lee,Sun Young Kim,Yeon Jung Lim 대한소아혈액종양학회 2022 Clinical Pediatric Hematology-Oncology Vol.29 No.2
B-cell precursor acute lymphoblastic leukemia (BCP-ALL), which is the most common type of ALL, has an excellent prognosis with long-term event-free survival of 90%. The malignancy has several genetic abnormalities that may influence patient prog-nosis. Rearrangements of the three immunoglobulin genes IGK (2p12), IGH (14q32), and IGL (22q11) are often seen, especially in non-Hodgkin lymphoma (NHL), but re-combination of these genes are uncommon. The translocation, t(14;22)(q32;q11) has been reported in only 9 B-cell leukemia/lymphoma cases, but there has been no re-port about the clinical feature and prognosis of BCP-ALL with t(14;22)(q32;q11). In this paper, we describe the first pediatric case of BCP-ALL with t(14;22)(q32;q11) who presented with a very high white blood cell (WBC) count. He achieved cytogenetic complete remission after induction chemotherapy, and negative minimal residual disease (MRD) at the end of consolidation.
Fourier series expansion method for plated-structures
Deng, Jiann-Gang,Cheng, Fu-Ping Techno-Press 1999 Structural Engineering and Mechanics, An Int'l Jou Vol.8 No.4
This work applies a structural analysis method based on an analytical solution from the Fourier series which transforms a half-range cosine expansion into a static solution involving plated structures. Two sub-matrices of in-plane and plate-bending problems are also formulated and coupled with the prescribed boundary conditions for these variables, thereby providing a convenient basis for a numerical solution. In addition, the plate connection are introduced by describing the connection between common boundary continuity and equilibrium. Moreover, a simple computation scheme is proposed. Numerical results are then compared with finite element results, demonstrating the numerical scheme's versatility and accuracy.
SINICA CORPUS; Design Methodology for Balanced Corpora
( Keh Jiann Chen ),( Chu Ren Huang ),( Li Ping Chang ),( Hui Li Hsu ) 한국언어정보학회 1996 국제 워크샵 Vol.1996 No.-
The Academia Sinica Balanced Corpus (Sinica Corpus) is the first balanced Chinese corpus with part-of-speech tagging. The corpus (Sinica 2.0) is open to the research community through the WWW (http://www.sinica.edu.tw/ftms-bin/ kiwi.sh). Current size of the corpus is 3.5 million words, and the immediate expansion target is five million words. Each text In the corpus is classified and marked according to five criteria: genre, style, mode, topic, and source. The feature values of these classifications are assigned in a hierarchy. Subcorpora can be defined with a specific set of attributes to serve different research purposes. Texts in the corpus are segmented according to the word segmentation standard proposed by the ROC Computational Linguistic Society. Each segmented word is tagged with its part-of-speech. Linguistic patterns and language structures can be extracted from the tagged corpus via a corpus inspection program which has the functions of KWIC searching, filtering, statistics, printing, and collocation.
Association of CYP2E1, STK15 and XRCC1 Polymorphisms with Risk of Breast Cancer in Malaysian Women
Chong, Eric Tzyy Jiann,Goh, Lucky Poh Wah,See, Edwin Un Hean,Chuah, Jitt Aun,Chua, Kek Heng,Lee, Ping-Chin Asian Pacific Journal of Cancer Prevention 2016 Asian Pacific journal of cancer prevention Vol.17 No.2
Background: Breast cancer is the most common type of cancer affecting Malaysian women. Recent statistics revealed that the cumulative probability of breast cancer and related deaths in Malaysia is higher than in most of the countries of Southeast Asia. Single nucleotide polymorphisms (SNPs) in CYP2E1 (rs6413432 and rs3813867), STK15 (rs2273535 and rs1047972) and XRCC1 (rs1799782 and rs25487) have been associated with breast cancer risk in a meta-analysis but any link in Southeast Asia, including Malaysia, remained to be determined. Hence, we investigated the relationship between these SNPs and breast cancer risk among Malaysian women in the present case-control study. Materials and Methods: Genomic DNA was isolated from peripheral blood of 71 breast cancer patients and 260 healthy controls and subjected to polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Results: Our study showed that the c1/c2 genotype or subjects with at least one c2 allele in CYP2E1 rs3813867 SNP had significantly increased almost 1.8-fold higher breast cancer risk in Malaysian women overall. In addition, the variant Phe allele in STK15 rs2273535 SNP appeared to protect against breast cancer in Malaysian Chinese. No significance association was found between XRCC1 SNPs and breast cancer risk in the population. Conclusions: This study provides additional knowledge on CYP2E1, STK15 and XRCC1 SNP impact of risk of breast cancer, particularly in the Malaysian population. From our findings, we also recommend Malaysian women to perform breast cancer screening before 50 years of age.